Powering the Possible for those battling Pediatric Cancer
Neuroblastoma affects 1 in 100,000 children and is responsible for 1 in 7 pediatric cancer deaths. Dell is joining a team of parents, genetic and translational medicine scientists and pediatric oncologists trailblazing personalized medicine to fight to treat this deadly pediatric cancer.
- Meet the "Dream Team"
Neuroblastoma and Medulloblastoma Translational Research Consortium
Children with cancer need our help. Van Andel Research Institute, the NMTRC, and parents of children with neuroblastoma and medulloblasto...- Friends of Will - Pediatric Cancer Neuroblastoma - HomeThe Friends of Will Cancer Foundation is a 501(c)3 tax-exempt public charity dedicated to doing our part to help save the lives of childr...
TGen Home PageCopyright 2009, The Translational Genomics Research Institute (TGen) 445 N. Fifth Street, Phoenix, AZ 85004 phone 602.343.8400 toll free ...
Cancer Research - Van Andel InstituteVAI conducts biomedical research, with a focus on cancer and Parkinson disease and with an emphasis on translating scientific research re...
Dell Powering the PossibleDell is powering the possible to fight childhood cancer through IT-enabled healthcare, corporate funding and employee volunteerism.- On May 16-17, 2012 Dell hosted the NMTRC Symposium to discuss updates and progress towards finding a cure for Neuroblastoma and Medulloblastoma
- Dell's CMO, Karen Quintos, and TGen's Dr. Jeff Trent kicked off the day and welcomed participants...
- May 16, 2012 Proclaimed "Fight Pediatric Cancer Day" in Austin and Round Rock, Texas
- How can the family foundations work together to use social media to get the word out and help with fundraising?








